Semaglutide is FDA approved under the brand name Wegovy for weight loss and weight maintenance (along with diet and exercise) in people 12 years and older who have been diagnosed with obesity and in adults who are considered overweight and have at least one weight-related medical condition
Inadequate glycaemic control alongside continued hunger requires prompt attention
Kuraoka S, Oda M, Ohba T, Mitsubuchi H, Iwai-Shimada M, Tatsuta N, Kamijima M, Nakamura K, Katoh T (2024) Association between prenatal mercury exposure and pediatric neurodevelopment: the Japan Environment and Childrens Study
A total of 296 participants without a history of significant alcohol consumption were randomly assigned to active treatment
Consumer expenditure on skincare and cosmetics, influenced by rising living standards, increasing disposable incomes, and the growing number of working women in the workforce, primarily drives glutathione consumption
Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography